RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort

Emilia Scalzulli, Claudia Ielo, Cristina Luise, Paolo Musiu, Maria Laura Bisegna, Ida Carmosino, Giovanni Manfredi Assanto, Maurizio Martelli, Massimo Breccia

Blood Advances · 2022 · 16 citations · 7 references

DOIFull text

Open access

Concepts

References

7